Research & Development



  等到匈奴軍隊跟牧人都不滿伊秩斜暴政的時候,她再出面,告訴所有匈奴人,伊秩斜病重,是被魔鬼纏身,現如今已然不能說話了。   長安城的宵禁自從大軍走了之後,就再也沒有開禁,大軍明明都離開了長安附近的軍兵,卻比以往更多。大大香蕉一本道国产   大巫師吃力的撕扯著劉陵身上的甲冑急促的道︰“已經做完了,每一個匈奴子民如今都知道,在遙遠的西方有一片水草豐茂的土地正等著我們去放牧,在那里,沒有白災,沒有嚴寒,只有開滿鮮花的草原跟波光粼粼的湖泊。更沒有凶惡的漢人,只有一些懦弱的可以供我們驅使的野人。”尹人在线大香蕉最快   李敢肯定的道︰“我甚至敢肯定匈奴人的斥候,就在那座山頭瞅著我們。”   “大戰在來年。”香蕉伊人影院在观看视频   “匈奴人應該能看見我們是嗎?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo